BARRETTS-ESOPHAGUS AND MARKERS OF MALIGNANT POTENTIAL

被引：8
作者：
WRIGHT, TA
KINGSNORTH, AN
机构：
[1] Department of Surgery, University of Liverpool, Liverpool
来源：
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 1994年 / 6卷 / 08期
关键词：
METAPLASIA; BARRETTS ESOPHAGUS; ONCOGENES; ANEUPLOIDY; GENES; P53; SUPPRESSOR; TUMOR;
D O I：
10.1097/00042737-199408000-00003
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The incidence of Barrett's cancer is rising rapidly yet endoscopic surveillance is still controversial because of its low detection rate and poor cost-effectiveness. Markers of high risk independent of dysplasia are currently being sought to improve surveillance. Promising new markers are-being assessed; aneuploidy, p53, adenomatous polyposis coli gene, c-erb B2 and the epidermal growth factor receptor have potential, but prospective studies are required.
引用
收藏
页码：656 / 662
页数：7
相关论文
共 43 条
  • [1] Pera M., Cameron A.J., Trastek V.F., Carpenter H.A., Zinsmeister A.R., Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction, Gastroenterology, 104, pp. 510-513, (1993)
  • [2] Blot W.J., Devesa S.S., Kneller R.W., Fraumeni J.F., Rising incidence of adenocarcinoma of the esophagus and gastric cardia, JAMA, 265, pp. 1287-1289, (1991)
  • [3] Skinner D.B., Walther B.C., Riddell R.H., Schmidt H., Iascone C., Demeester T.R., Barrett’s oesophagus. Comparison of benign and malignant cases, Ann Surg, 198, pp. 554-566, (1983)
  • [4] Sprung J., Ellis F.H., Gibb S.P., Incidence of adenocarcinoma in Barrett’s esophagus [abstract], Am J Gastroenterol, 79, (1984)
  • [5] Sampliner R.E., Kogan F.J., Morgan T.R., Tripp M., Progression-regression of Barrett’s esophagus [abstract], Gastroenterology, 88, (1985)
  • [6] Robertson C.S., Mayberry J.F., Nicholson D.A., James P.D., Atkinson M., Value of endoscopic surveillance in the detection of neoplastic change in Barrett’s esophagus, Br J Surg, 75, pp. 760-763, (1988)
  • [7] Hameeteman W., Tytgat G.N.J., Houtoff H.J., Van Den Tweel J.G., Barrett’s esophagus: Development of dysplasia and adenocarcinoma, Gastroenterology, 96, pp. 1249-1256, (1989)
  • [8] Skinner D.B., The incidence of cancer in Barrett’s esophagus varies according to series, In Benign Lesions of the Esophagus and Cancer: Answers to 210 Questions, pp. 764-765, (1989)
  • [9] Williamson W.A., Ellis F.H., Gibb S.P., Shihian D.M., Aretz H.T., Heatley G.J., Et al., Barrett’s esophagus. Prevalence and incidence of adenocarcinoma, Intern Med, 151, pp. 2212-2216, (1991)
  • [10] Iftikar S.Y., James P.D., Steele R.J.C., Hardcastle J.D., Atkinson M., Length of Barrett’s oesophagus: An important factor in the development of dysplasia and adenocarcinoma, Gut, 33, pp. 1155-1158, (1992)
12345